Pilot single-arm open label study to assess the effectiveness of topical amlexanox in promoting wound healing and collagen 7 expression in patients with Dystrophic Epidermolysis bullosa

Department of Dermatology Venereology and Leprology0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1. Patients with clinical diagnosis of dystrophic EB confirmed by IFM and/or molecular diagnosis
•2. Patients will be eligible for recruitment irrespective of gender.
•3. Treatment naÃ¯ve patients, which have not taken any treatment in the past and not on any systemic antibiotics

•1.Patients who have received any treatment in the past e.g. patients on topical/systemic antibiotics etc. in the last 6 weeks
•2.Patients with frank secondary bacterial infection or sepsis
•3.Patients with infected wounds
•4.Age <3 years

发起方

Department of Dermatology Venereology and Leprology